Activity of Brazilian and Bulgarian propolis against different species of Leishmania

Memorias do Instituto Oswaldo Cruz

Volumn 102, Issue 1, 2007, Pages 73-77

  Machado, Gérzia Maria De Carvalho ^a   Leon, Leonor Laura ^a   De Castro, Solange Lisboa ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Chemical composition; Leishmania; Leishmaniasis; Natural products; Propolis

Indexed keywords

LEISHMANIA AMAZONENSIS; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR;

EID: 33847151827     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762007000100012     Document Type: Article

References (39)

1. Akendengue B, Ngou-Milama E, Laurens A, Hocquemiller R 1999. Recent advances in the fight against leishmaniasis with natural products. Parasite 6: 3-8.
2. Almeida MC, Cuba-Cuba CA, Moraes MA, Miles MA 1996. Dissemination of Leishmania (Viannia) braziliensis. J Comp Pathol 115: 311-316.
3. Bankova VS 2005. Chemical diversity of propolis and the problem of standardization. J Ethnopharmacol 100: 114-117.
4. Bankova VS, De Castro SL, Marcucci MC 2000. Propolis: recent advances in search on chemistry and plant origins. Apidologie 31: 3-15.
5. Croft SL, Yardley V 2002. Chemotherapy of leishmaniasis. Curr Pharm Design 8: 319-342.
6. Cunha IBS, Salomão K, Shimizu M, Bankova VS, Custódio AR, De Castro SL, Marcucci MC 2004. Anti-trypanosomal activity of Brazilian propolis from Apis mellifera. Chem Pharm Bull 52: 602-604.
7. Cysne-Filkelstein L, Temporal RM, Alves F, Leon LL 1998. Leishmania amazonensis: long-term cultivation of axenic amastigotes is associated to metacyclogenesis of promastigotes. Exp Parasitol 89: 58-62.
8. Dantas AP, Olivieri BP, Gomes FHM, De Castro SL 2005. Treatment of Trypanosoma cruzi-infected mice with propolis promotes changes in the immune response. J Ethnopharmacol 103: 187-193.
9. Dantas AP, Salomão K, Barbosa HS, De Castro SL 2006. The effect of Bulgarian propolis against Trypanosoma cruzi. Mem Inst Oswaldo Cruz 101: 207-211.
10. Davidson RN 1999. Visceral leishmaniasis in clinical practice. J Infec Dis 39: 112-116.
11. De Castro SL 2001. Propolis: Biological and pharmacological activities. Therapeutic uses of this bee-product. Ann Rev Biomed Sci 3: 49-83.
12. De Castro SL, Higashi KO 1995. Effect of different formulations of propolis on mice infected with Trypanosoma cruzi. J Ethnopharmacol 46: 55-58.
13. Fournet A, Munoz V 2002. Natural products as trypanocidal, antileishmanial and antimalarial drugs. Curr Top Med Chem 2: 1215-1237.
14. Fournet A, Barrios AA, Muñoz V 1994. Leishmanicidal and trypanocidal activities of Bolivian medicinal plants. J Ethnopharmacol 41: 19-37.
15. Fournet A, Ferreira ME, Rojas-De-Arias A, Torres-De-Ortiz S, Fuentes S, Nakayama H, Schinini A, Hocquemiller R 1996. In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis. Antimicrob Agents Chemother 40: 2447-2451.
16. Garnier T, Croft SL 2002. Topical treatment for cutaneous leishmaniasis. Curr Opin Investigat Drugs 3: 538-544.
17. Hegazi AG, Abd-El-Hady FK, Abd-Allah FA 2000. Chemical composition and antimicrobial activity of European propolis. Zeit Naturforsch 55C: 70-75.
18. Hepburn NC 2000. Cutaneous leishmaniasis. Clin Exper Dermatol 25: 363-370.
19. Howard MK, Pharoah MM, Ashall F, Miles MA 1991. Human urine stimulates growth of Leishmania in vitro. Trans R Soc Trop Med Hyg 85: 477-479.
20. Jones TC, Johnson Jr WD, Barretto AC, Lago E, Badaro R, Cerf B, Reed SG, Netto EM, Tada MS, Franca TF 1987. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 156: 73-83.
21. Kujungiev A, Tsvetkova I, Serkedjieva Y, Bankova VS, Christov R, Popov S 1999. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J Ethnopharmacol 64: 235-240.
22. Kumazawa S, Yoneda M, Shibata I, Kanaeda J, Hamasaka T, Nakayama T 2003. Direct evidence for the plant origin of Brazilian propolis by the observation of honeybee behavior and phytochemical analysis. Chem Pharm Bull 51: 740-742.
23. Lainson R 1983. The American leishmaniasis: some observations on their ecology and epidemiology. Trans R Soc Trop Med Hyg 77: 569-596.
24. Lainson R, Shaw JJ, Silveira FT, Braga RR 1987. American visceral leishmaniasis: on the origin of Leishmania (Leishmania) chagasi. Trans R Soc Trop Med Hyg 81: 517.
25. Marcucci MC, Bankova VS 1999. Chemical composition, plant origin and biological activity of Brazilian propolis. Curr Top Phytochem 2: 115-123.
26. Marcucci MC, Ferreres F, Garcia-Viguera C, Bankova VS, De Castro SL, Dantas AP, Valente PH, Paulino N 2001. Phenolic compounds from Brazilian propolis with pharmacological activities. J Ethnopharmacol 74: 105-112.
27. Mishima S, Ono Y, Araki Y, Akao Y, Nozawa Y 2005. Two related cinnamic acid derivatives from Brazilian honey bee propolis, baccharin and drupanin, induce growth inhibition in allografted sarcoma S-180 in mice. Biol Pharm Bull 28: 1025-1030.
28. Newman DJ, Cragg GM, Snader KM 2003. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66: 1022-1037.
29. Paulino N, Dantas AP, Bankova VS, Longhi DT, Scremin A, De Castro SL, Calixto JB 2003. Bulgarian propolis induces analgesic and anti-inflammatory effects in mice and inhibits in vitro contraction of airway smooth muscle. J Pharmacol Sci 93: 307-313.
30. Pereira AS, Norsell M, Cardoso JN, Aquino-Neto, FR, Ramos MFS 2000. Rapid screening of polar compounds in Brazilian propolis by high-temperature high-resolution gas chromatography-mass spectrometry. J Agr Food Chem 48: 5226-5230.
31. Pisco L, Kordian M, Peseke K, Feist H, Michalik D, Estrada E, Carvalho J, Hamilton G, Rando D, Quincoces J 2006. Synthesis of compounds with antiproliferative activity as analogues of prenylated natural products existing in Brazilian propolis. Eur J Med Chem 41: 401-407.
32. Prytzyk E, Dantas AP, Salomão K, Pereira AS, Bankova VS, De Castro SL, Aquino-Neto FR 2003. Flavonoids and trypanocidal activity of Bulgarian propolis. J Ethnopharmacol 88: 189-193.
33. Salomão K, Dantas AP, Borba CM, Campos LC, Machado DG, Aquino Neto FR, De Castro SL 2004. Chemical composition and microbicidal activity of extracts from Brazilian and Bulgarian propolis. Lett Appl Microbiol 38: 87-92.
34. Sawaya ACHF, Palma AM, Caetano FM, Marcucci MC, Cunha IBS, Araújo CEP, Shimizu MT 2002. Comparative study of in vitro methods used to analyse the activity of propolis extracts with different compositions against species of Candida. Lett Appl Microbiol 35: 203-207.
35. Shamsuzzaman SM, Furuya M, Korenaga M, Imamura K, Hashiguchi Y 1999. Use of urine samples from healthy humans, nephritis patients or other animals as an alternative to fetal calf serum in the culture of Leishmania (Leishmania) donovani in vitro. Ann Trop Med Parasitol 93: 613-620.
36. Teixeira EW, Negri G, Meira RM, Message D, Salatino A 2005. Plant origin of green propolis: bee behavior, plant anatomy and chemistry. Evid-Based Complement Alternat Med 2: 85-92.
37. Trusheva B, Popova M, Naydenski H, Tsvetkova I, Rodriguez JG, Bankova VS 2004. New polyisoprenylated benzophenones from Venezuelan propolis. Fitoterapia 75: 683-689.
38. Weniger B, Robledo S, Arango GJ, Deharo E, Aragon R, Muñoz V, Callapa J, Lobstein A, Anton R 2001. Antiprotozoal activities of Colombian plants. J Ethnopharmacol 78: 193-200.
39. WHO 2004. Le-ishmaniasis [http://www.who.int/tdr/diseases/leish/].